Antony M. Paul

Array ( [id] => 2589522 [patent_doc_number] => 04970202 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-11-13 [patent_title] => 'Pharmaceutical compositions containing non-steroidal anti-inflammatory drugs' [patent_app_type] => 1 [patent_app_number] => 7/383283 [patent_app_country] => US [patent_app_date] => 1989-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3959 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/970/04970202.pdf [firstpage_image] =>[orig_patent_app_number] => 383283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2629125 [patent_doc_number] => 04916125 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-04-10 [patent_title] => 'Method of treating migraine' [patent_app_type] => 1 [patent_app_number] => 7/377989 [patent_app_country] => US [patent_app_date] => 1989-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1041 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/916/04916125.pdf [firstpage_image] =>[orig_patent_app_number] => 377989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2596351 [patent_doc_number] => 04923875 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-05-08 [patent_title] => 'Method for treatment of mast cell-mediated dermatologic disorders' [patent_app_type] => 1 [patent_app_number] => 7/377572 [patent_app_country] => US [patent_app_date] => 1989-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1467 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/923/04923875.pdf [firstpage_image] =>[orig_patent_app_number] => 377572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2637738 [patent_doc_number] => 04914125 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-04-03 [patent_title] => '(S)-emopamil for the treatment of migraine' [patent_app_type] => 1 [patent_app_number] => 7/375996 [patent_app_country] => US [patent_app_date] => 1989-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1205 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/914/04914125.pdf [firstpage_image] =>[orig_patent_app_number] => 375996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2671683 [patent_doc_number] => 04983621 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-01-08 [patent_title] => 'Medicaments' [patent_app_type] => 1 [patent_app_number] => 7/375913 [patent_app_country] => US [patent_app_date] => 1989-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2346 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/983/04983621.pdf [firstpage_image] =>[orig_patent_app_number] => 375913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2710106 [patent_doc_number] => 05017607 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-05-21 [patent_title] => 'Method to treat Parkinsons disease' [patent_app_type] => 1 [patent_app_number] => 7/374273 [patent_app_country] => US [patent_app_date] => 1989-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2353 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/017/05017607.pdf [firstpage_image] =>[orig_patent_app_number] => 374273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2743276 [patent_doc_number] => 05028611 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-07-02 [patent_title] => 'Treatment for cocaine use' [patent_app_type] => 1 [patent_app_number] => 7/373385 [patent_app_country] => US [patent_app_date] => 1989-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5310 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/028/05028611.pdf [firstpage_image] =>[orig_patent_app_number] => 373385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2603372 [patent_doc_number] => 04948793 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-08-14 [patent_title] => 'Treatment of autoimmune diseases with the morpholinoethyl ester of mycophenolic acid, and derivatives thereof' [patent_app_type] => 1 [patent_app_number] => 7/373413 [patent_app_country] => US [patent_app_date] => 1989-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7070 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/948/04948793.pdf [firstpage_image] =>[orig_patent_app_number] => 373413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2601764 [patent_doc_number] => 04912096 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-03-27 [patent_title] => 'Method for preventing or treating depression employing an ace inhibitor' [patent_app_type] => 1 [patent_app_number] => 7/371161 [patent_app_country] => US [patent_app_date] => 1989-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2687 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/912/04912096.pdf [firstpage_image] =>[orig_patent_app_number] => 371161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2624762 [patent_doc_number] => 04956361 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-09-11 [patent_title] => 'New combination products having an antidepressant action' [patent_app_type] => 1 [patent_app_number] => 7/370425 [patent_app_country] => US [patent_app_date] => 1989-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1972 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/956/04956361.pdf [firstpage_image] =>[orig_patent_app_number] => 370425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2877224 [patent_doc_number] => 05118708 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-06-02 [patent_title] => 'Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents' [patent_app_type] => 1 [patent_app_number] => 7/371351 [patent_app_country] => US [patent_app_date] => 1989-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6645 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/118/05118708.pdf [firstpage_image] =>[orig_patent_app_number] => 371351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2557200 [patent_doc_number] => 04960759 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-10-02 [patent_title] => 'Pharmacological use of uridine in the treatment of nervous disorders' [patent_app_type] => 1 [patent_app_number] => 7/367615 [patent_app_country] => US [patent_app_date] => 1989-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2666 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/960/04960759.pdf [firstpage_image] =>[orig_patent_app_number] => 367615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2596815 [patent_doc_number] => 04975430 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-12-04 [patent_title] => 'CNQX and its analogs as therapeutics for degenerative neural diseases' [patent_app_type] => 1 [patent_app_number] => 7/367993 [patent_app_country] => US [patent_app_date] => 1989-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 2753 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/975/04975430.pdf [firstpage_image] =>[orig_patent_app_number] => 367993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2708199 [patent_doc_number] => 05041446 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-08-20 [patent_title] => 'Method for inhibiting the development of tolerance in the analgesic treatment with morphine' [patent_app_type] => 1 [patent_app_number] => 7/362755 [patent_app_country] => US [patent_app_date] => 1989-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1694 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/041/05041446.pdf [firstpage_image] =>[orig_patent_app_number] => 362755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2743482 [patent_doc_number] => 05028622 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-07-02 [patent_title] => 'Administration of amino acids as treatment for neurodegenerative disorders' [patent_app_type] => 1 [patent_app_number] => 7/363351 [patent_app_country] => US [patent_app_date] => 1989-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5036 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/028/05028622.pdf [firstpage_image] =>[orig_patent_app_number] => 363351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2671098 [patent_doc_number] => 05026721 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-06-25 [patent_title] => 'Amino acid nutritional supplement and regimen for enhancing physical performance through sound nutrition' [patent_app_type] => 1 [patent_app_number] => 7/361295 [patent_app_country] => US [patent_app_date] => 1989-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3326 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/026/05026721.pdf [firstpage_image] =>[orig_patent_app_number] => 361295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2671912 [patent_doc_number] => 04983632 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-01-08 [patent_title] => 'Use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism, and the compositions obtained' [patent_app_type] => 1 [patent_app_number] => 7/361490 [patent_app_country] => US [patent_app_date] => 1989-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3565 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/983/04983632.pdf [firstpage_image] =>[orig_patent_app_number] => 361490 [rel_patent_id] =>[rel_patent_doc_number] =>)